GlassScriptPhysician profile
Paul E Kim
NPI 1790777332
$11,282.56
in general payments reported to CMS, 2019-2025
50 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $438 · 2021: $1,355 · 2022: $1,662 · 2023: $2,101 · 2024: $2,076 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,135.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,198.77 | 2019-2025 | Cardiomems, Diamondback Coronary, Xience Skypoint |
| Abiomed | $1,187.50 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $1,054.74 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $674.16 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $521.52 | 2019-2025 | Repatha, Repatha |
| Inari Medical, INC. | $500.08 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $471.81 | 2019-2025 | Andexxa, Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $437.89 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $436.59 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.69 | 2019-2025 | Jardiance |
| Atricure, INC. | $389.74 | 2023 | |
| Boston Scientific Corporation | $372.73 | 2019-2025 | Watchman Access System, Cds - Mct/Cem Monitoring, Lux-Dx Insertable Cardiac Monitor |
| Edwards Lifesciences Corporation | $325.43 | 2019-2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $292.39 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $283.24 | 2019-2025 | Kengreal |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $259.41 | 2024 | |
| Philips North America LLC | $254.51 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Pfizer INC. | $227.88 | 2019-2025 | |
| Penumbra, INC. | $190.86 | 2023-2024 | Penumbra System, Indigo System |
| Angiodynamics, INC. | $176.05 | 2024-2025 | Alphavac |
| Medtronic Vascular, INC. | $166.59 | 2019-2020 | |
| Stryker Corporation | $147.50 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $122.52 | 2022-2025 | Corevalve Evolut R |
| Sanofi-Aventis U.S. LLC | $107.37 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $102.87 | 2021-2025 | Optimizer |
| Biosense Webster, INC. | $96.64 | 2021-2023 | Carto 3 |
| Cvrx, INC. | $85.43 | 2023-2025 | Barostim Neo System |
| Vital Connect, INC | $74.09 | 2023-2025 | Vitalpatch Rtm |
| Shockwave Medical, INC | $59.67 | 2022-2025 | |
| Cardiovascular Systems INC. | $59.59 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $47.29 | 2019 | |
| Daiichi Sankyo INC. | $46.44 | 2021-2022 | |
| Novo Nordisk INC | $45.65 | 2024-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $45.02 | 2022 | |
| Teleflex LLC | $42.74 | 2025 | Supercross, Guideliner |
| Thrombolex, INC. | $37.30 | 2024 | Bashir Endovascular Catheter |
| Davol INC. | $33.29 | 2020 | |
| United Therapeutics Corporation | $32.46 | 2023 | Tyvaso |
| Kestra Medical Technology Services, INC. | $30.36 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $27.00 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Recor Medical INC | $25.48 | 2024 | Paradise Renal Denervation System |
| Nuwellis, INC. | $25.21 | 2019 | |
| Arbor Pharmaceuticals, INC. | $25.02 | 2019 | |
| Alnylam Pharmaceuticals INC. | $21.25 | 2023 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $20.28 | 2024 | |
| Cardiva Medical, INC. | $19.08 | 2024 | Optowire |
| Kiniksa Pharmaceuticals, LTD. | $19.05 | 2023 | Arcalyst |
| Terumo Medical Corporation | $18.71 | 2024 | Optitorque, Metacross Otw |
| Glaxosmithkline, LLC. | $18.38 | 2023 | Shingrix |
| Cordis US Corp. | $16.29 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.